TABLE 5.
Drug resistance among isolates of the Beijing and EAI lineages
| Resistant pattern | No. (%) of isolates
|
Crude OR (95% CI) | Adjusted ORa (95% CI) | P value | |
|---|---|---|---|---|---|
| Beijing lineage (n = 98) | EAI lineages (n = 150) | ||||
| Monoresistance to any one anti-TB drugb | 8 (8.2) | 19 (12.7) | 0.61 (0.26-1.46) | 1.88 (0.83-4.23) | 0.13 |
| Resistance to any two anti-TB drugsc | 14 (14.3) | 13 (8.7) | 1.76 (0.79-3.92) | 0.59 (0.23-1.53) | 0.28 |
| MDR TBd | 21 (21.4) | 2 (1.3) | 20.18 (4.61-88.33) | 3.20 (1.34-7.67) | 0.009 |
a
Adjusted for the patient's history of exposure to anti-TB drugs.
b
The anti-TB drugs tested were streptomycin, isoniazid, rifampin, and ethambutol.
c
Strains resistant to any two anti-TB drugs except a combination of isoniazid and rifampin.
d
Strains resistant to at least isoniazid and rifampin.